TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 93 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2016. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $17,000 | -71.2% | 35,000 | -20.5% | 0.00% | -66.7% |
| Q1 2019 | $59,000 | +18.0% | 44,000 | 0.0% | 0.01% | +20.0% |
| Q4 2018 | $50,000 | -58.7% | 44,000 | 0.0% | 0.01% | -54.5% |
| Q3 2018 | $121,000 | -22.9% | 44,000 | 0.0% | 0.01% | -21.4% |
| Q2 2018 | $157,000 | +18.9% | 44,000 | +2.3% | 0.01% | +16.7% |
| Q1 2018 | $132,000 | -30.2% | 43,000 | +43.3% | 0.01% | -29.4% |
| Q4 2017 | $189,000 | -7.8% | 30,000 | 0.0% | 0.02% | -10.5% |
| Q3 2017 | $205,000 | -4.2% | 30,000 | 0.0% | 0.02% | -9.5% |
| Q2 2017 | $214,000 | -22.5% | 30,000 | 0.0% | 0.02% | -22.2% |
| Q1 2017 | $276,000 | +128.1% | 30,000 | 0.0% | 0.03% | +125.0% |
| Q4 2016 | $121,000 | +31.5% | 30,000 | +25.0% | 0.01% | +50.0% |
| Q3 2016 | $92,000 | -10.7% | 24,000 | 0.0% | 0.01% | -11.1% |
| Q2 2016 | $103,000 | – | 24,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 354,300 | $7,068,000 | 2.77% |
| Opaleye Management Inc. | 169,700 | $3,385,515,000 | 2.64% |
| Broadfin Capital, LLC | 959,247 | $19,137,000 | 2.01% |
| Novo Holdings A/S | 900,000 | $17,955,000 | 1.75% |
| Eventide Asset Management | 300,900 | $6,003,000 | 0.84% |
| EAM Investors, LLC | 152,595 | $3,044,000 | 0.62% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 497,858 | $9,932,000 | 0.51% |
| Granite Point Capital Management, L.P. | 40,000 | $798,000 | 0.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,191 | $8,981,000 | 0.33% |
| TFS CAPITAL LLC | 133,070 | $2,655,000 | 0.23% |